跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
黃 綉文
副教授
,
藥理學科
https://orcid.org/0000-0001-6894-4698
電子郵件
shiuwen
tmu.edu
tw
h-index
406
引文
12
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2000
2025
每年研究成果
概覽
指紋
網路
專案
(14)
研究成果
(30)
類似的個人檔案
(6)
指紋
查看啟用 Shiu-Wen Huang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin A
100%
Survivin
80%
Antiangiogenic
75%
Neoplasm
57%
Malignant Neoplasm
56%
Protein P53
55%
Hydroxamic Acid Derivative
54%
Colorectal Cancer
50%
Mitogen Activated Protein Kinase P38
46%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
44%
Hydroxamic Acid
42%
Vasculotropin Receptor 2
40%
Phosphotransferase
38%
Vasculotropin
31%
Angiogenesis Inhibitor
26%
Mouse
25%
Disease
23%
Tumor Growth
22%
Benzimidazole Derivative
22%
Matrigel
21%
Thromboxane Receptor
21%
Western Blot
20%
Breast Cancer
20%
Interleukin 6
20%
Anthraquinone
19%
Benzimidazole
19%
Thromboxane Receptor Blocking Agent
16%
Glycoside
16%
Benzofuran
16%
Vasculotropin Receptor
16%
Mevinolin
16%
Naphthoquinone
16%
Lipopolysaccharide
16%
Thrombus
16%
Atherosclerosis
16%
Thromboxane A2 Receptor Blocking Agent
16%
Omalizumab
16%
Thrombosis
16%
Immunoglobulin E
16%
Chronic Urticaria
16%
Protein Tyrosine Phosphatase
16%
Head and Neck Squamous Cell Carcinoma
16%
Matrix-Assisted Laser Desorption/Ionization
16%
Alcohol Derivative
16%
Clinical Research
16%
Quaternary Ammonium Derivative
16%
Ribose
16%
Diseases
16%
Glioblastoma
16%
Thrombin
16%
Medicine and Dentistry
Lymph Duct
75%
Endothelial Cell
66%
Antiangiogenic Activity
41%
Angiogenesis
37%
Vasculotropin A
33%
Thrombocyte Aggregation
33%
Blood Clotting
33%
Lymphangiogenesis
28%
Vasculotropin C
25%
Vasculotropin
25%
Benzimidazole Derivative
25%
Platelet
25%
Vasculotropin Receptor 2
23%
Cell Proliferation
21%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
20%
Focal Adhesion Kinase
19%
Survivin
16%
Phosphoprotein Phosphatase 2A
16%
Hydroxamic Acid
16%
Protein P53
16%
Thrombocyte Function
16%
Vasculotropin Receptor
16%
Cyclooxygenase 2
16%
Interleukin 6
16%
Lipopolysaccharide
16%
Thromboxane Receptor
16%
Thromboxane Receptor Blocking Agent
16%
Thrombosis
16%
Brain Injury
16%
Glioblastoma
16%
Immunosuppressive Drug
16%
Lichen (Disease)
16%
Neoplasm
16%
Vascular Endothelial Cell
13%
Tumor Cell
13%
Malignant Neoplasm
13%
Promoter Region
12%
Signaling Molecule
12%
Angiogenesis Inhibitor
11%
Lung Metastasis
11%
In Vitro
11%
Ex Vivo
10%
Antiangiogenic
10%
Artery Thrombosis
10%
Matrigel
9%
Disease
9%
Bromodeoxyuridine
9%
Immunoblotting
9%
Brain Ischemia
8%
Arachidonic Acid
8%
Biochemistry, Genetics and Molecular Biology
Survivin
38%
STAT3
38%
Angiogenesis
35%
Antiangiogenic Activity
33%
Interleukin 6
33%
Mouse
22%
P53
22%
Promoter Region
21%
Cancer Cell
20%
Phosphoprotein Phosphatase
20%
Lymphangiogenesis
19%
Janus Kinase 1
19%
Coagulation System
16%
Thrombocyte Function
16%
Lipopolysaccharide
16%
Thrombocyte Aggregation
16%
Vascular Endothelial Growth Factor C
16%
Cell Maturation
16%
Omalizumab
16%
Vascular Endothelial Growth Factor A
16%
Immunoglobulin E
16%
Cell Death
16%
Vascular Endothelial Growth Factor
16%
Cancer Stem Cell
16%
VEGF Receptors
16%
Cyclooxygenase
16%
Protein Tyrosine Phosphatase
16%
P21
15%
Platelet
13%
Cell Proliferation
12%
Phosphotransferase
12%
Kinase
12%
MAP2K3
11%
Gene Signature
11%
Gene Expression
11%
P38 Mitogen-Activated Protein Kinases
10%
Histone Deacetylase
10%
Acetylation
8%
Luciferase
7%
Thrombin
6%
Single-Nucleotide Polymorphism
6%
Messenger RNA
6%
Small Interfering RNA
6%
Western Blot
5%
Cell Cycle Progression
5%
Phosphatase
5%
Notch Signaling Pathway
5%
JUNB
5%
PPM1A
5%
RGS14
5%
